《內房》旭輝(00884.HK)百億公司債重組:傳方案獲四隻債券持有人批准
內媒引述市場消息指,旭輝(00884.HK)在境內推進的百億規模公司債重組取得新進展。據悉,旗下「H21旭輝2」重組方案已獲債權人會議表決通過,該券餘額29.73億元人民幣。
截至目前,旭輝控股已對七隻、本金額合計超過百億元的公司債發起整體重組,其中四隻債券持有人已投票贊成,對應餘額60.69758億元。除「H21旭輝2」外,其餘三隻分別為「H20旭輝3」、「H20旭輝2」及「H21旭輝01」。剩餘三隻債券重組方案仍在推進中。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.